| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |